Not a traditional drug phase: observational group of NAFLD for Non-Alcoholic Fatty Liver Disease
It is an watch-and-measure (no experimental treatment required) study of non alcoholic fatty liver disease (NAFLD) patients with a calculated sample size of 500. Liver biopsy proved NAFLD patients will be recruited in this study for 10 years follow-up.
Official registry: https://clinicaltrials.gov/study/NCT03635541 · Beijing Friendship Hospital · enrollment listed as 500
What this phase means
This is an observational study. You are not assigned a new experimental drug. Researchers measure what already happens in your care or in daily life.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
This listing is observational (StudyType). The registry does not assign a new experimental drug as the study intervention.
They plan to enroll about 500 people at Beijing. Taking part typically means study visits and measurements plus check-ins.
Official title (unrewritten)
Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease
Interventions: observational group of NAFLD
Primary outcome (registry wording): fibrosis progrssion
Who it is for (from inclusion criteria)
- Ages 18 Years to 70 Years
Who the registry excludes
- 1\. Patients with other liver diseases including viral hepatitis, alcoholic liver diseases, autoimmune liver diseases, drug induced liver diseases, genetic metabolic liver disease
- 2\. Patients undergone bariatric surgery. 3. HIV infected patients. 4. Pregnant women. 5. Patients with severe diseases with expected survival less than 2 years. 6. Patients had followings before liver biopsy:
- Hepatocellular carcinoma or suspected liver cancer,
- Decompensated cirrhosis: including ascites, hepatic encephalopathy, esophageal varices bleeding or other complications of decompensated cirrhosis or hepatocelluar carcinoma;
- Undergone liver transplantation surgery. 7.Patients with any other reasons not suitable for the study
Public study contact (from the registry)
Hong You, Doctor
Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.
Sites listed on ClinicalTrials.gov
1 listed- Beijing Friendship Hospital, Capital Medical University — Beijing, Beijing Municipality, China (recruiting)
FAQ about this NCT record
Is NCT03635541 still recruiting?
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT03635541?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT03635541?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary